LQDA max pain for the Oct 16, 2026 expiry is $37.50. The last price, $27.38, is 27.0% below it. Call wall $30 · put floor $25.
What the institutional money is doing on LQDA right now — dark pool, options positioning, and where the news and the money disagree. Free.
The money right now
Dark pool share
40.7% (market avg 52%)
Dark pool volume vs its norm
0.8×
Short share of that
52.0% (norm 58%)
Dark pool share: 41% off-exchange — 11pp below the market
Off-exchange prints never touch the public book, so they move size without moving the quote. That is the point of using them. Most of the day cleared on the lit market — either there was nothing to hide, or the large players sat out. Short share of the off-exchange piece: 52% vs a 58% norm.
Source: FINRA · Fri 10/9 close
What it means: Dark-pool activity in LQDA was quiet on October 9, with volume at about 0.83 of its normal level and a short share (52%) below its usual 58%, which reads as mild accumulation rather than heavy selling. Options positioning leans toward calls (put-call ratio 0.62), though no new option positions were recorded.
News vs the money
Investors with $100,000 in losses can join a Liquidia fraud investigation led by SBS Law
This is a legal notice from a law firm, and the options data shows more call positioning than puts with no new large positions, so the money is not reacting to it.
Business Wire · 10/07
⚡ DIVERGENCELiquidia stock falls 6.1% after Wells Fargo cuts its rating
The downgrade is negative, while the options mix leans toward calls and off-exchange volume shows quiet accumulation, so the money is not confirming the bearish tone.
Defense World · 10/05
⚡ DIVERGENCELiquidia stock plunges 57% after a patent litigation setback
A drop this large would normally bring heavy put buying, yet the options data shows more calls than puts and no new large positions, which is a notable mismatch.
Zacks Investment Research · 10/01
United Therapeutics wins a patent dispute against Liquidia, sending its stock up nearly 13%
This news is positive for United Therapeutics and negative for Liquidia, but it does not change the options balance, which still favors calls.
Zacks Investment Research · 10/01
A court ruling sends one drugmaker soaring while its rival struggles, but the legal fight is not over
The story signals an unresolved legal outcome, and the money data shows mild accumulation and call-leaning options with no large new positions, so there is no clear confirmation either way.
24/7 Wall Street · 10/01
What is a “divergence”?
A divergence is when the news narrative and the institutional money flow point in opposite directions — a bearish headline while large call premium is bought, or heavy dark-pool selling under a bullish story. It signals the crowd and the desks may disagree.
How to read these numbers
Dark-pool volume — The share of trading executed off-exchange, at wholesalers and dark pools. About half of all US share volume prints there on an ordinary day, so the level by itself says almost nothing. What carries information is the distance from this name’s own recent norm, and whether the off-exchange size ran above its usual.
Off-exchange short share — How much of that off-exchange volume was sold short. The median across all listed names is about 49%, because wholesalers filling retail buy orders sell short and cover later. A reading near half is plumbing, not a bearish vote — compare it to the same name’s own 20-day norm.
Max pain — The price where the most options expire worthless — positioning often gravitates toward it near expiry.
Call wall / Put floor — Strikes with the heaviest call/put open interest — they often act as short-term resistance and support.
Put/Call ratio — Below ~0.7 leans bullish (more calls); above ~1 leans defensive (more puts).